Nadine Wong

Special to TheStreet.com
Nadine Wong
By This Author:
« Back
Page 1 of 4
Article

How to Evaluate Biotechs That Aren't Profitable Yet

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:50PM 01/23/02

Article

This Earnings Season Could Be a Good One for Biotechs

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:27PM 01/16/02

Article

Don't Write Off ImClone Just Yet

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

09:55AM 01/10/02

Article

ImClone's Potential Could Be Worth the Risk

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

08:03AM 01/03/02

Article

Biotech's Prognosis Improves at Year-End

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:58PM 12/26/01

Article

The Amgen-Immunex Deal Is the Right Prescription

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

09:25AM 12/20/01

Article

Protein Design Labs Is Still Worth Owning

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

10:54AM 12/13/01

Article

Who Wins, Who Loses in the MedImmune-Aviron Deal

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

08:10AM 12/06/01

Article

How to Play Stem-Cell Research Stocks

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

10:20AM 11/29/01

Article

Some Biotech Mutual Funds Worth Considering

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:31PM 11/20/01

« Back
Page 1 of 4
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now.

Keep on top of the market and the critical information you need to make more profitable investing decisions.

  • Cramer's Daily Booyah!
  • Before the Bell

Privacy Policy

See All Free Newsletters

Premium Stock Ideas